Ligia B. Schmitd, Hannah Hafner, Ayobami Ward, Elham Asghari Adib, Natalia P. Biscola, Rafi Kohen, Mitre Athaiya, Meghan Tuttle, Manav Patel, Rachel E. Williamson, Emily Desai, Julianna Bennett, Grace Saxman, David Wilborn, Jaisha Shumpert, Xiao-Feng Zhao, Riki Kawaguchi, Daniel H. Geschwind, Ahmet Hoke, Peter Shrager, Catherine A. Collins, Leif A. Havton, Ashley L. Kalinski, Roman J. Giger
{"title":"Deletion of murine Sarm1 results in a microenvironment that delays peripheral nerve regeneration after injury","authors":"Ligia B. Schmitd, Hannah Hafner, Ayobami Ward, Elham Asghari Adib, Natalia P. Biscola, Rafi Kohen, Mitre Athaiya, Meghan Tuttle, Manav Patel, Rachel E. Williamson, Emily Desai, Julianna Bennett, Grace Saxman, David Wilborn, Jaisha Shumpert, Xiao-Feng Zhao, Riki Kawaguchi, Daniel H. Geschwind, Ahmet Hoke, Peter Shrager, Catherine A. Collins, Leif A. Havton, Ashley L. Kalinski, Roman J. Giger","doi":"10.1126/scitranslmed.adp9155","DOIUrl":null,"url":null,"abstract":"<div >Upon injury to the mammalian peripheral nervous system (PNS), severed axons undergo rapid SARM1-dependent programmed axon death (Wallerian degeneration), but a potential role for <i>Sarm1</i> in PNS regeneration remains unclear. We show that in mouse dorsal root ganglia with their axons cut, <i>Sarm1</i> delayed the activation of injury-induced transcriptional programs associated with axon outgrowth and immune function. After sciatic nerve crush in <i>Sarm1<sup>−/−</sup></i> mice, axons rapidly extended through the nerve injury site, but growth stalled more distally. Slow axon regeneration in the distal nerve was accompanied by delayed induction of the nerve repair response by Schwann cells and delayed clearance of disintegrating myelin. Nerve fibers did regenerate in <i>Sarm1<sup>−/−</sup></i> mice, but regeneration was delayed, and axons exhibited reduced caliber and aberrant target innervation. Tibial nerve action potentials were weaker, and recovery of hind paw function was delayed but ultimately not impaired. Grafting of mouse <i>Sarm1<sup>−/−</sup></i> nerves into wild-type mice and mouse wild-type nerves into <i>Sarm1<sup>−/−</sup></i> mice revealed that the <i>Sarm1<sup>−/−</sup></i> nerve microenvironment was hostile to wild-type axon regeneration and, conversely, that <i>Sarm1<sup>−/−</sup></i> axons robustly grew into mouse wild-type nerve grafts. Ex vivo, the appearance of c-Jun–labeled Schwann cells in cultured mouse <i>Sarm1<sup>−/−</sup></i> nerves was delayed but could be accelerated by pharmacological inhibition of ErbB kinase. Our study highlights the opposing functions of <i>Sarm1</i> deficiency in dorsal root ganglia and distal nerves in mice, the consequence of which is delayed PNS regeneration.</div>","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"17 819","pages":""},"PeriodicalIF":14.6000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/scitranslmed.adp9155","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Upon injury to the mammalian peripheral nervous system (PNS), severed axons undergo rapid SARM1-dependent programmed axon death (Wallerian degeneration), but a potential role for Sarm1 in PNS regeneration remains unclear. We show that in mouse dorsal root ganglia with their axons cut, Sarm1 delayed the activation of injury-induced transcriptional programs associated with axon outgrowth and immune function. After sciatic nerve crush in Sarm1−/− mice, axons rapidly extended through the nerve injury site, but growth stalled more distally. Slow axon regeneration in the distal nerve was accompanied by delayed induction of the nerve repair response by Schwann cells and delayed clearance of disintegrating myelin. Nerve fibers did regenerate in Sarm1−/− mice, but regeneration was delayed, and axons exhibited reduced caliber and aberrant target innervation. Tibial nerve action potentials were weaker, and recovery of hind paw function was delayed but ultimately not impaired. Grafting of mouse Sarm1−/− nerves into wild-type mice and mouse wild-type nerves into Sarm1−/− mice revealed that the Sarm1−/− nerve microenvironment was hostile to wild-type axon regeneration and, conversely, that Sarm1−/− axons robustly grew into mouse wild-type nerve grafts. Ex vivo, the appearance of c-Jun–labeled Schwann cells in cultured mouse Sarm1−/− nerves was delayed but could be accelerated by pharmacological inhibition of ErbB kinase. Our study highlights the opposing functions of Sarm1 deficiency in dorsal root ganglia and distal nerves in mice, the consequence of which is delayed PNS regeneration.
期刊介绍:
Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research.
The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases.
The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.